David L. Snitman
Keine laufenden Positionen mehr
Karriereverlauf von David L. Snitman
Ehemalige bekannte Positionen von David L. Snitman
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ARRAY TECHNOLOGIES, INC. | Direktor/Vorstandsmitglied | 11.10.2010 | 24.10.2012 |
| Geschäftsführer | 01.05.1998 | 02.03.2015 | |
| Gründer | 01.01.1998 | 30.06.2015 | |
| Corporate Officer/Principal | 02.03.2015 | 30.06.2015 | |
| AMGEN INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.12.1981 | - |
BaroFold, Inc.
 BaroFold, Inc. Pharmaceuticals: MajorHealth Technology BaroFold, Inc. develops and commercializes protein therapeutics. Its services include protein refolding, protein analytical and aggregate characterization, formulation stability and immunogenicity studies, and microbial expression. The company was founded by Matthew Seefeldt, Matthew Brewer, John F. Carpenter, Ted Randolph, Timothy C. Rodell, and Lyndal K. Hesterberg in 2009 and is headquartered in Aurora, CO. | Direktor/Vorstandsmitglied | - | - |
Ausbildung von David L. Snitman
| Northeastern University | Undergraduate Degree |
| The University of Colorado | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
Operativ
| Director/Board Member | 2 |
| Chief Operating Officer | 1 |
| Founder | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| AMGEN INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Array BioPharma, Inc.
 Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Array BioPharma, Inc. is a biopharmaceutical company. Its focus is on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and other high-burden diseases. The company's products are BRAFTOVI and MEKTOVI. Its portfolio includes Binimetinib, Selumetinib, Encorafenib, Filanesib, Ipatasertib, Varltinib, Danoprevir, ARRY-797, Larotrectinib, Tucatinib, ARRY-382, Motolimod, Prexasertib, GDC-0575, LOXO-292, LOXO-195, and AK-1830. The company was founded by Kevin Koch, Anthony D. Piscopio, K. C. Nicolaou, and David L. Snitman in 1998 and is headquartered in Boulder, CO. | Health Technology |
BaroFold, Inc.
BaroFold, Inc. Pharmaceuticals: MajorHealth Technology BaroFold, Inc. develops and commercializes protein therapeutics. Its services include protein refolding, protein analytical and aggregate characterization, formulation stability and immunogenicity studies, and microbial expression. The company was founded by Matthew Seefeldt, Matthew Brewer, John F. Carpenter, Ted Randolph, Timothy C. Rodell, and Lyndal K. Hesterberg in 2009 and is headquartered in Aurora, CO. | Health Technology |
- Börse
- Insiders
- David L. Snitman
- Erfahrung